Target lesion revascularisation in patients treated with a sirolimus-eluting or paclitaxel-eluting stent

Heart

Volumn 93, Issue 6, 2007, Pages 694-697

  Maeng, Michael ^a,b   Jensen, Lisette Okkels ^c   Rasmussen, Klaus ^d   Lassen, Jens Flensted ^b   Krusell, Lars Romer ^b   Thayssen, Per ^c   Thuesen, Leif ^b  

^a Skeiby Sygehus   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c ODENSE UNIVERSITY HOSPITAL   (Denmark)

^d AALBORG UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

PACLITAXEL; RAPAMYCIN;

ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DENMARK; DRUG ELUTING STENT; FOLLOW UP; HEART MUSCLE REVASCULARIZATION; HUMAN; IMPLANTATION; MAJOR CLINICAL STUDY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; REVASCULARIZATION; TARGET LESION REVASCULARIZATION;

ANALYSIS OF VARIANCE; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY RESTENOSIS; CORONARY STENOSIS; DENMARK; DRUG DELIVERY SYSTEMS; EQUIPMENT DESIGN; HUMANS; LOGISTIC MODELS; PACLITAXEL; REGISTRIES; RISK FACTORS; SIROLIMUS; STENTS; TREATMENT OUTCOME;

EID: 34249340876     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2006.100594     Document Type: Article

References (18)

1. Stone GW, Ellis SG, Cox DA, et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 2004;350:221-31.
2. Moses JW, Leon MB, Popma JJ, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003;349:1315-23.
3. Morice MC, Serruys PW, Sousa JE, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002;346:1773-80.
4. Stone GW, Ellis SG, Cox DA, et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 2004;350:221-31.
5. Ong ATL, Serruys PW, Aoki J, et al. The unrestricted use of paclitaxel- versus sirolimus-eluting stents for coronary artery disease in an unselected population: one-year results of the Taxus-stent evaluated at Rotterdam Cardiology Hospital (T-SEARCH) Registry. J Am Coll Cardiol 2005;45:1135-41.
6. Goy JJ, Stauffer JC, Siegenthaler M, et al. A prospective randomized comparison between Paclitaxel and Sirolimus stents in the real world of interventional cardiology: the TAXi trial. J Am Coll Cardiol 2005;45:308-11.
7. Kastrati A, Mehilli J, von Beckerath N, et al. Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis. JAMA 2005;293:165-71.
8. Dibra A, Kastrati A, Mehilli J, et al. Paclitaxel-eluting or Sirolimus-eluting stents to prevent restenosis in diabetic patients. N Engl J Med 2005;353:663-70.
9. Windecker S, Remondino A, Eberli FR, et al. Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization. N Engl J Med 2005;353:653-62.
10. Morice MC, Colombo A, Meier B, et al. REALITY: a prospective randomized, multicenter comparison study of the Cypher Sirolimus-eluting and Taxus paclitaxel-eluting stent systems. JAMA 2006;295:895-904.
11. Kastrati A, Dibra A, Eberie S, et al. Sirolimus-eluting stents vs Paclitaxel-eluting stents in patients with coronary artery disease. JAMA 2005;294:819-25.
12. Hong SJ, Kim MH, Ahn TH, et al. Multiple predictors of coronary restenosis after drug-eluting stent implantation in diabetic patients. Heart 2006;92:1119-24.
13. Roiron C, Sanchez P, Bouzamondo A, et al. Drug eluting stents: an updated meta-analysis of randomised controlled trials. Heart 2006;92:641-9.
14. Concato J, Shah N, Horwitz RI. Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med 2000;342:1887-92.
15. Benson K, Hartz AJ. A comparison of observational studies and randomized, controlled trials. N Engl J Med 2000;342:1878-86.
16. Kelboek H, Thuesen L, Helqvist S, et al. The stenting coronary arteries in non-stress/benestent disease (SCANDSTENT) trial. J Am Coll Cardiol 2006;47:449-55.
17. Kastrati A, Dibra A, Mehilli J, et al. Predictive factors of restenosis after coronary implantation of sirolimus- or paclitaxel-eluting stents. Circulation 2006;113:2293-300.
18. Ruygrok PN, Melkert RN, Morel MA, et al. Does angiography six months after coronary intervention influence management and outcome. Benestent II investigators. J Am Coll Cardiol 1999;34:1507-11.